Three researchers awarded more than $920,000 to advance research into EMDR therapy

New research fellowships from MQ Mental Health Research and the EMDRIA Foundation will investigate how EMDR therapy could improve trauma treatment for military personnel and veterans, people with PTSD, and young people at risk of psychosis


Three early-career researchers have been awarded prestigious research fellowships to investigate new ways of using and improving Eye Movement Desensitisation and Reprocessing (EMDR) therapy, through a partnership between MQ Mental Health Research and the EMDRIA Foundation.


The three fellowships represent a combined investment of $922,370 and will support Dr Elizabeth Penix-Smith, Dr Ross Murray and Dr Beatrice Todesco to undertake ambitious research aimed at strengthening the evidence behind EMDR and improving trauma treatment.
The awards form part of the MQ Fellows programme, MQ’s flagship programme supporting talented early-career scientists as they establish independent careers in mental health research. The wider Fellows programme supports researchers asking challenging questions that could transform the understanding, prevention and treatment of mental illness The programme aims both to retain talented researchers and increase diversity within mental health research.


Through the partnership with the EMDRIA Foundation, a dedicated EMDR fellowship stream was established to strengthen EMDR research in the United States and Canada and help develop the next generation of trauma-focused mental health researchers. Fellows also receive mentorship and support from an international panel of EMDR experts.


Using AI to find the right PTSD treatment for military personnel and veterans
At the Walter Reed Army Institute of Research in the United States, Dr Elizabeth Penix-Smith will investigate how EMDR performs in routine care for military personnel and veterans with post-traumatic stress disorder (PTSD).


Her project will examine existing treatment records for people who have received one of three established PTSD therapies: EMDR, Cognitive Processing Therapy (CPT) or Prolonged Exposure (PE). The study will compare how well these approaches work in real-world US military and veterans’ healthcare and will use machine learning to investigate which personal and clinical factors are associated with better outcomes from each treatment.


Dr Penix-Smith’s ambition is to move trauma care away from trial and error and towards more personalised treatment, giving patients and clinicians better evidence to help them choose the therapy most likely to work for them.


Dr Penix-Smith said:
“I’m incredibly grateful to MQ and the EMDRIA Foundation for supporting this work. I’m excited about this opportunity to contribute to the broader EMDR community and efforts to better support Service Members and Veterans.”


Could exercise help people get more from EMDR?
Dr Ross Murray, at the University of Toronto in Canada, will investigate an innovative but simple idea: whether a short period of exercise immediately before EMDR could help people with PTSD get more from their therapy.


People with PTSD can find it difficult to regulate their body’s response to psychological stress, which may affect how ready they feel to engage with difficult memories during therapy. Dr Murray will compare standard EMDR with EMDR preceded by 10 to 15 minutes of moderate exercise in first responders, such as firefighters, paramedics and police, and military personnel with PTSD.


If successful, the study could identify a relatively low-cost and accessible way to make trauma therapy more effective. It could also improve researchers’ understanding of the relationship between the body’s stress response and psychological recovery.


Dr Murray said:
“The fellowship gives me the chance to test an idea that is a little different, work more closely with clinical researchers and practitioners, and hopefully produce research that can have a meaningful impact on how we support people experiencing PTSD.”

Treating trauma earlier in young people at risk of psychosis
At the Centre for Addiction and Mental Health (CAMH) in Canada, Dr Beatrice Todesco will explore whether EMDR could help young people who have experienced trauma and are showing early warning signs that put them at increased risk of psychosis.


The study will involve 30 young people aged 16 to 35 who are considered at clinical high risk of psychosis and are also experiencing trauma-related symptoms. Participants will receive EMDR adapted for people experiencing early psychosis-related symptoms, with researchers
monitoring changes in trauma, anxiety, depression, early psychosis symptoms, everyday functioning and quality of life.


The research could provide the first North American evidence about whether EMDR can be used safely and effectively with young people at clinical high risk of psychosis.


Dr Todesco said:
“I’m thrilled to be named an MQ Fellow, an important milestone in my career. I hope this research will change how we understand and treat trauma in young people at risk of psychosis and, ultimately, help make trauma-focused interventions part of their care.”

Building the next generation of EMDR research
The three awards mark an important milestone in the partnership between MQ Mental Health Research and the EMDRIA Foundation, bringing together MQ’s experience in developing and managing international research funding programmes with the Foundation’s expertise and networks in EMDR.


The dedicated EMDR Fellowship was established to increase research capacity within academic institutions and support early-career researchers to develop independent careers investigating EMDR. The programme is intended to strengthen the evidence base for the therapy, support research capable of informing clinical practice and treatment guidelines and help build a sustainable pipeline of researchers working in the field.


“Research is essential to the continued advancement of EMDR therapy, but its greatest value comes from what we learn and how that knowledge can inform clinical care,” said Michael Bowers, Executive Director of EMDRIA. “These fellowships represent an investment in developing the next generation of EMDR researchers and expanding the questions we can investigate. As this partnership grows, we remain focused on supporting rigorous, clinically relevant research that strengthens the evidence base and helps move EMDR therapy forward.”


The partnership is already looking ahead. A further EMDRIA-MQ Foundation Research Fellowship round is planned, expanding eligibility to researchers in the United States, Canada and Mexico as the programme continues to build research capacity around EMDR


About EMDR
Eye Movement Desensitisation and Reprocessing, commonly known as EMDR, is a psychological therapy used in the treatment of trauma-related mental health problems including PTSD. The dedicated EMDR Fellowship stream supports research designed to advance understanding of EMDR and its application in mental healthcare.


About the MQ Fellows programme
The MQ Fellows Award is the flagship early-career funding programme of MQ Mental Health Research. It supports promising researchers from around the world to establish independent careers while undertaking innovative research with the potential to improve the understanding, detection, prevention and treatment of mental illness.


About EMDR International Association (EMDRIA)
EMDR International Association (EMDRIA) is a professional membership association dedicated to advancing the education, practice and research of Eye Movement Desensitization and Reprocessing (EMDR) therapy. Representing more than 20,000 members across 75 countries, EMDRIA supports the professional development of EMDR therapists through continuing education, professional standards, certification, research and community engagement. Through its work, EMDRIA strives to strengthen the evidence base for EMDR therapy, promote excellence in clinical practice and expand awareness of EMDR therapy as an effective treatment for trauma and other mental health challenges.


Learn more at www.emdria.org.

About the EMDRIA Foundation
The EMDRIA Foundation is dedicated to advancing Eye Movement Desensitization and Reprocessing (EMDR) therapy through investments in research, education and public awareness. As the philanthropic arm of EMDR International Association (EMDRIA), the Foundation supports initiatives that strengthen the evidence base for EMDR therapy, expand research opportunities and foster the next generation of researchers and clinicians. Through strategic partnerships and philanthropic support, the EMDRIA Foundation works to advance scientific understanding, inform clinical practice and broaden access to the benefits of EMDR therapy.


For more information, please contact Bryony Doughty: bdoughty@mqmentalhealth.org

Note regarding Dr Elizabeth Penix-Smith
The views, opinions, and findings contained in this interview are those of the speaker and do not necessarily reflect the views of the Department of War and should not be construed as an official DoW/Army position, policy or decision.